tiprankstipranks
Trending News
More News >
Medicenna Therapeutics Corp (MDNAF)
OTHER OTC:MDNAF
US Market

Medicenna Therapeutics Corp (MDNAF) Financial Statements

Compare
252 Followers

Medicenna Therapeutics Corp Financial Overview

Medicenna Therapeutics Corp's market cap is currently C$43.75M. The company's EPS TTM is $-0.03658405; its P/E ratio is -5.65; Medicenna Therapeutics Corp is scheduled to report earnings on February 13, 2026, and the estimated EPS forecast is $-0.04. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Mar 23Mar 22Mar 21Mar 20
Income Statement
Total RevenueC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross ProfitC$ -55.00KC$ -5.00KC$ -38.00KC$ -40.00K-
Operating IncomeC$ -21.63MC$ -19.66MC$ -22.30MC$ -17.19MC$ -8.21M
EBITDAC$ -12.97MC$ -18.67MC$ -22.54MC$ -17.25MC$ -8.27M
Net IncomeC$ -11.80MC$ -25.47MC$ -22.65MC$ -17.18MC$ -8.31M
Balance Sheet
Cash & Short-Term InvestmentsC$ 24.84MC$ 16.98MC$ 20.54MC$ 40.38MC$ 37.70M
Total AssetsC$ 28.38MC$ 19.13MC$ 23.46MC$ 42.25MC$ 38.00M
Total DebtC$ 168.00KC$ 0.00C$ 0.00C$ 34.00KC$ 67.31K
Net DebtC$ -24.67MC$ -16.98MC$ -20.54MC$ -30.34MC$ -22.63M
Total LiabilitiesC$ 9.29MC$ 13.94MC$ 2.62MC$ 4.11MC$ 1.85M
Stockholders' EquityC$ 19.09MC$ 5.19MC$ 20.84MC$ 38.15MC$ 36.15M
Cash Flow
Free Cash FlowC$ -16.52MC$ -16.26MC$ -23.58MC$ -15.31MC$ -8.95M
Operating Cash FlowC$ -16.49MC$ -16.26MC$ -23.58MC$ -15.31MC$ -8.95M
Investing Cash FlowC$ -33.00KC$ 0.00C$ 10.05MC$ 5.01MC$ -15.00M
Financing Cash FlowC$ 23.49MC$ 0.00C$ 3.88MC$ 18.26MC$ 44.28M
Currency in CAD

Medicenna Therapeutics Corp Earnings and Revenue History

Medicenna Therapeutics Corp Debt to Assets

Medicenna Therapeutics Corp Cash Flow

Medicenna Therapeutics Corp Forecast EPS vs Actual EPS